Press Releases

Date	Title	Company
28-Feb-2023	PharmiWeb.Jobs Announces New Recruitment Training Courses	PharmiWeb.Jobs
28-Feb-2023	MediClin AG: Disclosure of the preliminary figures of the 2022 financial year	MediClin AG
28-Feb-2023	PharmiWeb.Jobs Welcomes Chameleon International	Chameleon International
28-Feb-2023	PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)	PureTech Health plc
28-Feb-2023	Rhythm Pharmaceuticals Announces Acquisition of Xinvento B.V. and Portfolio of Investigational Therapeutics	Rhythm Pharmaceuticals
28-Feb-2023	Carterra expands best-in-class franchise with the launch of the LSAXT high-throughput SPR biosensor at SLAS 2023	Carterra
28-Feb-2023	serYmun Yeast Announces Preclinical Safety and Efficacy Data for Their Yeast-Based Vaccine Against Porcine Parvovirus (PPV)	serYmun Yeast
28-Feb-2023	Darolutamide receives approval for additional prostate cancer indication in Japan	ORION CORPORATION
28-Feb-2023	New Phase 3 data presented at WORLDSymposium™ reinforce Nexviazyme® (avalglucosidase alfa) as potential new standard of care for all people living with late-onset Pompe disease	Sanofi
28-Feb-2023	Alfa Laval Launches Best-in-class Heat Exchanger for Hygienic Applications	Alfa Laval
28-Feb-2023	Almirall opens the doors of its R&D centre to the biotech ZeClinics	Almirall
28-Feb-2023	HUTCHMED Completes Patient Enrollment of Phase II Registration Trial of Amdizalisib in Follicular Lymphoma in China	HUTCHMED
28-Feb-2023	Obesity in pregnant women could alter the structure and function of the placenta increasing the risk of poor health outcomes for both mother and baby	The Physiological Society
28-Feb-2023	Final Results	Spectral MD Holdings, Ltd
28-Feb-2023	Genprex Announces Groundbreaking Data from Non-Human Primate Study Evaluating Novel Gene Therapy to Treat Type 1 Diabetes at 16th Annual International Conference on Advanced Technologies & Treatment for Diabetes 2023	Genprex
28-Feb-2023	UK faces £50bn economic hit due to spiralling medicines levy	Association of the British Pharmaceutical Industry (ABPI)
28-Feb-2023	Rare disease community call for their unified voice to be heard in the fight for equitable care	Sanofi
28-Feb-2023	Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars	Relief Therapeutics Holding SA
28-Feb-2023	Global Drug Eruptions Treatment Market to reach US$ 7.1 billion by 2033, Antihistamines to account for 41% of all Treatments \| FMI Study	MARKITWIRED
28-Feb-2023	The Global Eosinophilic Granulomatosis with Polyangiitis Treatment Market Is Expected to Register Growth at 5.2% CAGR through 2033 \| FMI Study	MARKITWIRED